Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free MKSI Stock Alerts

MKS (MKSI) Financials

MKS logo
$304.99 +13.68 (+4.70%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$306.00 +1.01 (+0.33%)
As of 08/7/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for MKS

Annual Income Statements for MKS

This table shows MKS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 122 105 339 393 140 350 551 333 -1,841 190 295
Consolidated Net Income / (Loss)		 122 105 339 393 140 350 551 333 -1,841 190 295
Net Income / (Loss) Continuing Operations		 122 105 339 393 140 350 551 333 -1,841 190 295
Total Pre-Tax Income 		159 128 448 481 178 423 665 433 -1,928 180 304
Total Operating Income		 157 157 407 494 220 454 699 617 -1,554 498 528
Total Gross Profit		 363 1,295 891 980 830 1,049 1,380 1,547 1,642 1,708 1,837
Total Revenue		 814 1,295 1,916 2,075 1,900 2,330 2,950 3,547 3,622 3,586 3,931
Operating Revenue		 814 1,295 1,916 2,075 1,900 2,330 2,950 3,547 3,622 3,586 3,931
Total Cost of Revenue		 451 0.00 1,025 1,096 1,069 1,281 1,570 2,000 1,980 1,878 2,094
Operating Cost of Revenue		 451 - 1,025 1,096 1,069 1,281 1,570 2,000 1,980 1,878 2,094
Total Operating Expenses		 206 1,138 485 485 611 595 681 930 3,196 1,210 1,309
Selling, General & Admin Expense		 129 228 290 298 330 353 385 488 675 674 724
Research & Development Expense		 68 111 133 136 164 173 200 241 288 271 299
Amortization Expense		 6.76 36 46 44 67 55 55 146 295 245 247
Other Operating Expenses / (Income)		 - 731 0.49 0.40 6.60 - 0.00 0.00 2.00 5.00 2.00
Impairment Charge		 - 5.00 6.72 0.00 4.70 - 0.00 0.00 1,902 0.00 0.00
Restructuring Charge		 2.10 28 9.25 7.70 44 14 41 62 36 15 37
Other Special Charges / (Income)		 - - - 0.00 -6.80 0.00 0.00 -7.00 -2.00 0.00 0.00
Total Other Income / (Expense), net		 2.86 -29 41 -13 -42 -31 -34 -184 -374 -318 -224
Interest Expense		 0.14 31 31 17 44 29 25 177 364 341 222
Interest & Investment Income		 3.00 2.56 3.02 5.80 5.40 1.00 0.00 4.00 17 21 14
Other Income / (Expense), net		 - -1.24 69 -2.00 -3.30 -3.00 -9.00 -11 -27 2.00 -16
Income Tax Expense		 37 23 108 88 37 73 114 100 -87 -10 9.00
Basic Earnings per Share		 $2.30 $1.96 $6.26 $7.22 $2.57 $6.36 $9.95 $5.57 ($27.54) $2.82 $4.39
Weighted Average Basic Shares Outstanding		 53.28M 53.47M 54.14M 54.41M 54.70M 55.10M 55.40M 59.70M 66.80M 67.30M 67.30M
Diluted Earnings per Share		 $2.28 $1.94 $6.16 $7.14 $2.55 $6.33 $9.90 $5.56 ($27.54) $2.81 $4.37
Weighted Average Diluted Shares Outstanding		 53.56M 54.05M 55.07M 55M 55.10M 55.30M 55.70M 59.90M 66.80M 67.60M 67.70M
Weighted Average Basic & Diluted Shares Outstanding		 53.20M 53.50M 54.20M 54.40M 54.87M 55.22M 55.52M 66.67M 67.06M 67.38M 67.25M
Cash Dividends to Common per Share		 $0.68 $0.68 $0.71 $0.78 $0.80 $0.80 $0.86 $0.88 $0.88 $0.88 $0.88

Quarterly Income Statements for MKS

This table shows MKS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -69 15 23 62 90 52 62 74 107 84 175
Consolidated Net Income / (Loss)		 -69 15 23 62 90 52 62 74 107 84 175
Net Income / (Loss) Continuing Operations		 -69 15 23 62 90 52 62 74 107 84 175
Total Pre-Tax Income 		-80 19 22 60 79 59 72 84 89 102 213
Total Operating Income		 23 106 127 128 137 111 135 138 144 149 251
Total Gross Profit		 411 415 419 432 442 444 453 461 479 507 595
Total Revenue		 893 868 887 896 935 936 973 988 1,034 1,078 1,248
Operating Revenue		 893 868 887 896 935 936 973 988 1,034 1,078 1,248
Total Cost of Revenue		 482 453 468 464 493 492 520 527 555 571 653
Operating Cost of Revenue		 482 453 468 464 493 492 520 527 555 571 653
Total Operating Expenses		 388 309 292 304 305 333 318 323 335 358 344
Selling, General & Admin Expense		 162 170 161 167 176 185 175 180 184 190 200
Research & Development Expense		 70 70 66 70 65 70 76 76 77 81 76
Amortization Expense		 70 62 61 61 61 60 62 63 62 63 62
Other Operating Expenses / (Income)		 2.00 3.00 0.00 2.00 - 2.00 0.00 0.00 - 18 0.00
Restructuring Charge		 9.00 4.00 4.00 4.00 3.00 16 5.00 4.00 12 3.00 6.00
Other Special Charges / (Income)		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 3.00 0.00
Total Other Income / (Expense), net		 -103 -87 -105 -68 -58 -52 -63 -54 -55 -47 -38
Interest Expense		 98 96 117 69 59 56 57 55 54 50 42
Interest & Investment Income		 6.00 6.00 5.00 6.00 4.00 3.00 4.00 3.00 4.00 2.00 2.00
Other Income / (Expense), net		 -11 3.00 7.00 -5.00 -3.00 1.00 -10 -2.00 -5.00 1.00 2.00
Income Tax Expense		 -11 4.00 -1.00 -2.00 -11 7.00 10 10 -18 18 38
Basic Earnings per Share		 ($1.02) $0.22 $0.34 $0.92 $1.34 $0.77 $0.92 $1.10 $1.60 $1.24 $2.59
Weighted Average Basic Shares Outstanding		 66.80M 67M 67.30M 67.40M 67.30M 67.40M 67.20M 67.30M 67.30M 67.40M 67.60M
Diluted Earnings per Share		 ($1.01) $0.22 $0.33 $0.92 $1.34 $0.77 $0.92 $1.10 $1.58 $1.18 $2.41
Weighted Average Diluted Shares Outstanding		 66.80M 67.40M 67.50M 67.60M 67.60M 67.70M 67.40M 67.60M 67.70M 71.10M 72.70M
Weighted Average Basic & Diluted Shares Outstanding		 67.06M 67.20M 67.29M 67.30M 67.38M 67.07M 67.16M 67.17M 67.25M 67.54M 67.62M

Annual Cash Flow Statements for MKS

This table details how cash moves in and out of MKS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -78 6.34 100 309 -230 193 358 -57 -34 -161 -39
Net Cash From Operating Activities		 138 180 355 414 245 513 640 529 319 528 645
Net Cash From Continuing Operating Activities		 138 180 355 414 245 513 640 529 319 528 645
Net Income / (Loss) Continuing Operations		 122 105 339 393 140 350 551 333 -1,841 190 295
Consolidated Net Income / (Loss)		 122 105 339 393 140 350 551 333 -1,841 190 295
Depreciation Expense		 22 66 83 80 110 99 104 216 397 348 344
Amortization Expense		 - 24 11 4.70 15 3.00 2.00 108 33 30 26
Non-Cash Adjustments To Reconcile Net Income		 26 46 11 54 72 58 57 62 2,031 169 110
Changes in Operating Assets and Liabilities, net		 -32 -61 -88 -117 -93 3.00 -74 -190 -301 -209 -130
Net Cash From Investing Activities		 -167 -727 23 73 -947 -202 -205 -4,552 -84 -117 -145
Net Cash From Continuing Investing Activities		 -167 -727 23 73 -947 -202 -205 -4,552 -84 -117 -145
Purchase of Property, Plant & Equipment		 -12 -19 -31 -63 -64 -85 -87 -164 -87 -118 -148
Acquisitions		 -9.91 -940 - 0.00 -989 0.00 -268 -4,473 0.00 0.00 0.00
Purchase of Investments		 -386 -268 -230 -254 -246 -522 -497 -1.00 0.00 0.00 0.00
Sale of Property, Plant & Equipment		 - - - 0.00 42 0.00 0.00 9.00 3.00 1.00 3.00
Sale and/or Maturity of Investments		 241 500 211 389 310 405 647 77 0.00 0.00 0.00
Net Cash From Financing Activities		 -47 560 -280 -178 476 -122 -65 3,971 -259 -549 -562
Net Cash From Continuing Financing Activities		 -47 560 -280 -178 476 -122 -65 3,971 -259 -549 -562
Repayment of Debt		 - -165 -258 -117 -112 -84 -15 -1,213 -415 -2,642 -454
Repurchase of Common Equity		 -13 -1.55 - -75 - - - - 0.00 0.00 -45
Payment of Dividends		 -36 -36 -38 -42 -44 -44 -47 -52 -59 -59 -59
Issuance of Debt		 - 764 29 68 642 27 1.00 5,237 216 2,161 0.00
Other Financing Activities, net		 2.17 -0.45 -12 -11 -11 -21 -4.00 -1.00 -1.00 -9.00 -4.00
Other Net Changes in Cash		 - -6.90 1.81 - -3.20 - - - - - 23
Cash Interest Paid		 0.03 21 20 15 40 26 23 110 305 268 190
Cash Income Taxes Paid		 43 45 105 92 36 66 110 133 0.00 0.00 0.00

Quarterly Cash Flow Statements for MKS

This table details how cash moves in and out of MKS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 16 -30 5.00 11 -147 -59 19 23 -22 -106 42
Net Cash From Operating Activities		 181 67 122 163 176 141 165 197 142 53 243
Net Cash From Continuing Operating Activities		 181 67 122 163 176 141 165 197 142 53 243
Net Income / (Loss) Continuing Operations		 -69 15 22 62 91 52 62 74 107 84 174
Consolidated Net Income / (Loss)		 -69 15 22 62 91 52 62 74 107 84 174
Depreciation Expense		 96 88 87 87 86 85 87 86 86 85 86
Amortization Expense		 10 8.00 8.00 7.00 7.00 6.00 7.00 7.00 6.00 4.00 4.00
Non-Cash Adjustments To Reconcile Net Income		 116 37 47 55 60 43 23 25 19 38 18
Changes in Operating Assets and Liabilities, net		 28 -81 -42 -48 -68 -45 -14 5.00 -76 -158 -39
Net Cash From Investing Activities		 -34 -18 -26 -22 -51 -18 -27 -51 -49 -25 -55
Net Cash From Continuing Investing Activities		 -34 -18 -26 -22 -51 -18 -27 -51 -49 -25 -55
Purchase of Property, Plant & Equipment		 -34 -18 -27 -22 -51 -18 -29 -51 -50 -25 -54
Purchase of Investments		 - - - - - 0.00 - - 1.00 0.00 -1.00
Net Cash From Financing Activities		 -143 -72 -87 -144 -246 -180 -129 -128 -125 -137 -148
Net Cash From Continuing Financing Activities		 -143 -72 -87 -144 -246 -180 -129 -128 -125 -137 -148
Repayment of Debt		 -347 -809 -1,470 -129 -234 -115 -114 -113 -112 -1,296 -105
Payment of Dividends		 -15 -15 -15 -14 -15 -15 -15 -14 -15 -17 -17
Other Financing Activities, net		 4.00 -9.00 -2.00 -1.00 3.00 -5.00 - -1.00 2.00 -16 -26
Effect of Exchange Rate Changes		 - -7.00 -4.00 14 -26 -2.00 10 5.00 - 3.00 2.00

Annual Balance Sheets for MKS

This table presents MKS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1,273 2,212 2,414 2,614 3,416 3,904 4,540 11,495 9,118 8,590 8,796
Total Current Assets		 940 999 1,236 1,464 1,434 1,804 2,147 2,794 2,696 2,474 2,510
Cash & Equivalents		 228 229 334 644 415 608 966 909 875 714 675
Accounts Receivable		 102 249 300 295 341 393 443 720 603 615 651
Inventories, net		 153 276 339 385 462 501 577 977 991 893 921
Other Current Assets		 18 51 54 66 106 74 85 187 227 252 263
Plant, Property, & Equipment, net		 69 175 172 194 242 284 326 800 784 771 810
Total Noncurrent Assets		 265 1,039 1,006 956 1,741 1,815 2,067 7,901 5,638 5,345 5,476
Goodwill		 200 589 591 587 1,059 1,066 1,228 4,308 2,554 2,479 2,574
Intangible Assets		 44 408 366 320 565 512 576 3,173 2,619 2,272 2,140
Other Noncurrent Operating Assets		 21 32 38 39 112 230 263 420 465 594 762
Total Liabilities & Shareholders' Equity		 1,273 2,212 2,414 2,614 3,416 3,904 4,540 11,495 9,118 8,590 8,796
Total Liabilities		 112 970 825 741 1,393 1,543 1,653 7,012 6,646 6,268 6,077
Total Current Liabilities		 91 237 290 263 318 374 460 952 848 775 927
Short-Term Debt		 - 11 2.97 3.99 12 15 9.00 93 93 50 51
Accounts Payable		 23 69 83 84 88 111 168 426 327 341 407
Other Current Liabilities		 28 52 61 63 79 81 89 433 428 384 469
Total Noncurrent Liabilities		 21 733 535 478 1,075 1,169 1,193 6,060 5,798 5,493 5,150
Long-Term Debt		 - 601 390 344 872 815 808 4,834 4,696 4,488 4,150
Noncurrent Deferred & Payable Income Tax Liabilities		 2.66 66 62 48 72 59 99 783 640 504 474
Noncurrent Employee Benefit Liabilities		 13 45 52 56 44 50 49 138 151 141 149
Other Noncurrent Operating Liabilities		 5.43 21 32 30 87 245 237 305 311 360 377
Commitments & Contingencies		 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,161 1,242 1,589 1,873 2,023 2,361 2,887 4,483 2,472 2,322 2,719
Total Preferred & Common Equity		 1,161 1,242 1,589 1,873 2,023 2,361 2,887 4,483 2,472 2,322 2,719
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,161 1,242 1,589 1,873 2,023 2,361 2,887 4,483 2,472 2,322 2,719
Common Stock		 745 778 790 794 864 873 907 2,142 2,195 2,067 2,101
Retained Earnings		 427 495 796 1,085 1,181 1,487 1,991 2,272 373 503 711
Accumulated Other Comprehensive Income / (Loss)		 -11 -31 3.45 -5.66 -22 0.30 -11 69 -96 -248 -93

Quarterly Balance Sheets for MKS

This table presents MKS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 11,366 9,230 9,140 8,931 8,863 9,023 8,556 8,826 8,777 8,728 8,941
Total Current Assets		 2,748 2,728 2,775 2,661 2,648 2,668 2,426 2,484 2,536 2,545 2,774
Cash & Equivalents		 880 757 859 845 850 861 655 674 697 569 611
Accounts Receivable		 572 631 618 576 597 609 639 649 611 775 830
Inventories, net		 1,058 1,036 1,009 971 938 940 894 918 934 949 1,033
Other Current Assets		 237 303 288 268 262 258 238 243 294 252 300
Plant, Property, & Equipment, net		 794 777 761 766 759 770 774 801 769 795 798
Total Noncurrent Assets		 7,824 5,725 5,604 5,504 5,456 5,585 5,356 5,541 5,472 5,388 5,369
Goodwill		 4,327 2,575 2,540 2,511 2,495 2,567 2,496 2,570 2,563 2,565 2,580
Intangible Assets		 3,108 2,728 2,614 2,501 2,418 2,443 2,238 2,267 2,196 2,065 2,015
Other Noncurrent Operating Assets		 389 422 450 492 543 575 622 704 713 758 774
Total Liabilities & Shareholders' Equity		 11,366 9,230 9,140 8,931 8,863 9,023 8,556 8,826 8,777 8,728 8,941
Total Liabilities		 6,915 6,735 6,664 6,507 6,630 6,625 6,202 6,273 6,177 5,917 5,953
Total Current Liabilities		 876 835 838 721 740 781 781 832 886 2,291 2,424
Short-Term Debt		 88 88 87 50 50 50 50 51 51 1,398 1,399
Accounts Payable		 372 314 309 290 291 306 323 355 382 448 534
Other Current Liabilities		 416 433 442 381 399 425 408 426 453 445 491
Total Noncurrent Liabilities		 6,039 5,900 5,826 5,786 5,890 5,844 5,421 5,441 5,291 3,626 3,529
Long-Term Debt		 4,837 4,819 4,787 4,692 4,832 4,758 4,409 4,357 4,253 2,650 2,544
Noncurrent Deferred & Payable Income Tax Liabilities		 751 628 595 622 588 590 502 504 483 450 438
Noncurrent Employee Benefit Liabilities		 138 143 139 148 144 154 139 152 154 146 147
Other Noncurrent Operating Liabilities		 313 310 305 324 326 342 371 428 401 380 400
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 4,451 2,495 2,476 2,424 2,233 2,398 2,354 2,553 2,600 2,811 2,988
Total Preferred & Common Equity		 4,451 2,495 2,476 2,424 2,233 2,398 2,354 2,553 2,600 2,811 2,988
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 4,451 2,495 2,476 2,424 2,233 2,398 2,354 2,553 2,600 2,811 2,988
Common Stock		 2,154 2,168 2,180 2,201 2,042 2,053 2,067 2,078 2,090 2,104 2,093
Retained Earnings		 2,215 431 455 373 381 428 512 559 618 778 936
Accumulated Other Comprehensive Income / (Loss)		 82 -104 -159 -150 -190 -83 -225 -84 -108 -71 -41

Annual Metrics And Ratios for MKS

This table displays calculated financial ratios and metrics derived from MKS's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.18% 59.23% 47.91% 8.31% -8.45% 22.64% 26.61% 20.24% 2.11% -0.99% 9.62%
EBITDA Growth		 13.23% 37.82% 130.95% 1.36% -40.83% 62.08% 43.94% 16.83% -223.76% 176.28% 0.46%
EBIT Growth		 15.89% -0.37% 204.81% 3.47% -56.00% 108.31% 52.99% -12.17% -360.89% 131.63% 2.40%
NOPAT Growth		 4.70% 7.24% 139.20% 31.01% -57.00% 116.43% 54.18% -18.07% -329.25% 148.32% -2.53%
Net Income Growth		 5.63% -14.30% 223.57% 15.85% -64.27% 149.29% 57.43% -39.56% -652.85% 110.32% 55.26%
EPS Growth		 5.56% -14.91% 217.53% 15.91% -64.29% 148.24% 56.40% -43.84% -595.32% 110.20% 55.52%
Operating Cash Flow Growth		 35.70% 30.23% 97.24% 16.49% -40.91% 109.82% 24.76% -17.34% -39.70% 65.52% 22.16%
Free Cash Flow Firm Growth		 3,273.89% -837.34% 138.13% 12.62% -309.82% 156.95% -34.56% -2,123.41% 119.13% -25.39% -46.01%
Invested Capital Growth		 2.67% 182.66% 0.50% 4.53% 59.28% -1.24% 13.38% 219.31% -24.87% -3.76% 1.61%
Revenue Q/Q Growth		 -3.63% 21.90% 5.90% -2.41% -18.63% 37.44% 3.65% 9.98% -5.06% 1.19% 2.58%
EBITDA Q/Q Growth		 -8.50% 48.19% 11.41% -4.64% -5.67% 16.27% 5.71% 6.04% -14.87% 14.17% 0.46%
EBIT Q/Q Growth		 -9.45% 33.41% 14.14% -4.75% -12.31% 22.89% 6.01% -5.90% -9.41% 32.28% 0.99%
NOPAT Q/Q Growth		 -7.02% 31.70% 11.01% -2.56% -11.56% 22.61% 6.02% -5.27% -9.90% -7.27% 4.00%
Net Income Q/Q Growth		 -6.62% 23.53% 10.47% -1.50% -17.04% 26.22% 6.89% -22.56% -7.16% 512.90% 6.12%
EPS Q/Q Growth		 -6.56% 23.57% 10.20% -1.24% -17.74% 26.35% 6.45% -27.51% -6.13% 510.87% 5.81%
Operating Cash Flow Q/Q Growth		 6.56% 5.88% 8.58% 15.23% -19.25% 15.75% 8.11% -2.04% -0.93% -0.94% -5.01%
Free Cash Flow Firm Q/Q Growth		 3.23% 2.96% 0.20% 18.12% -9.63% 16.70% 21.27% -5.38% 32.89% 7.56% -34.45%
Invested Capital Q/Q Growth		 -2.17% -0.29% 1.84% -2.41% 0.13% 0.61% 0.03% 3.01% -1.60% -3.14% 0.61%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.61% 100.00% 46.53% 47.20% 43.71% 45.02% 46.78% 43.61% 45.33% 47.63% 46.73%
EBITDA Margin		 21.97% 19.02% 29.69% 27.79% 17.96% 23.73% 26.98% 26.22% -31.78% 24.48% 22.44%
Operating Margin		 19.25% 12.14% 21.22% 23.81% 11.57% 19.49% 23.69% 17.40% -42.90% 13.89% 13.43%
EBIT Margin		 19.25% 12.05% 24.82% 23.71% 11.40% 19.36% 23.39% 17.08% -43.65% 13.94% 13.02%
Profit (Net Income) Margin		 15.03% 8.09% 17.70% 18.93% 7.39% 15.02% 18.68% 9.39% -50.83% 5.30% 7.50%
Tax Burden Percent		 76.69% 81.90% 75.76% 81.68% 78.97% 82.74% 82.86% 76.91% 95.49% 105.56% 97.04%
Interest Burden Percent		 101.82% 82.02% 94.12% 97.74% 82.12% 93.79% 96.38% 71.45% 121.95% 36.00% 59.38%
Effective Tax Rate		 23.31% 18.10% 24.24% 18.32% 21.03% 17.26% 17.14% 23.09% 0.00% -5.56% 2.96%
Return on Invested Capital (ROIC)		 24.21% 13.39% 21.63% 27.64% 8.97% 15.90% 23.12% 8.50% -14.62% 8.39% 8.27%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.86% 23.40% 367.08% 31.59% 258.02% 0.86% 46.79% 1.04% -33.61% -0.29% 2.36%
Return on Net Nonoperating Assets (RNNOA)		 -13.30% -4.67% 2.33% -4.94% -1.76% 0.07% -2.12% 0.53% -38.33% -0.46% 3.43%
Return on Equity (ROE)		 10.91% 8.72% 23.96% 22.70% 7.21% 15.97% 21.00% 9.04% -52.94% 7.93% 11.70%
Cash Return on Invested Capital (CROIC)		 21.58% -82.08% 21.13% 23.21% -36.75% 17.14% 10.58% -96.10% 13.79% 12.22% 6.67%
Operating Return on Assets (OROA)		 12.54% 8.95% 20.56% 19.57% 7.18% 12.32% 16.34% 7.56% -15.34% 5.65% 5.89%
Return on Assets (ROA)		 9.79% 6.01% 14.66% 15.63% 4.66% 9.56% 13.05% 4.15% -17.86% 2.15% 3.39%
Return on Common Equity (ROCE)		 10.91% 8.72% 23.96% 22.70% 7.21% 15.97% 21.00% 9.04% -52.94% 7.93% 11.70%
Return on Equity Simple (ROE_SIMPLE)		 10.53% 8.44% 21.34% 20.97% 6.94% 14.82% 19.09% 7.43% -74.47% 8.18% 0.00%
Net Operating Profit after Tax (NOPAT)		 120 129 308 404 174 376 579 475 -1,088 526 512
NOPAT Margin		 14.76% 9.94% 16.08% 19.45% 9.14% 16.12% 19.63% 13.38% -30.03% 14.66% 13.03%
Net Nonoperating Expense Percent (NNEP)		 0.35% -10.01% -345.45% -3.95% -249.05% 15.04% -23.67% 7.46% 18.99% 8.68% 5.91%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 5.04% -14.98% 7.66% 7.40%
Cost of Revenue to Revenue		 55.40% 0.00% 53.47% 52.80% 56.29% 54.98% 53.22% 56.39% 54.67% 52.37% 53.27%
SG&A Expenses to Revenue		 15.87% 17.60% 15.14% 14.37% 17.39% 15.15% 13.05% 13.76% 18.64% 18.80% 18.42%
R&D to Revenue		 8.40% 8.54% 6.92% 6.54% 8.64% 7.42% 6.78% 6.79% 7.95% 7.56% 7.61%
Operating Expenses to Revenue		 25.35% 87.86% 25.30% 23.39% 32.14% 25.54% 23.08% 26.22% 88.24% 33.74% 33.30%
Earnings before Interest and Taxes (EBIT)		 157 156 476 492 217 451 690 606 -1,581 500 512
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 179 246 569 577 341 553 796 930 -1,151 878 882
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.53 2.41 3.07 1.78 2.87 3.42 3.28 1.23 2.76 3.02 3.94
Price to Tangible Book Value (P/TBV)		 1.94 12.23 7.72 3.46 14.49 10.33 8.73 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.18 2.31 2.54 1.61 3.05 3.47 3.21 1.56 1.88 1.95 2.73
Price to Earnings (P/E)		 14.53 28.61 14.37 8.50 41.31 23.08 17.16 16.60 0.00 36.90 36.35
Dividend Yield		 2.02% 1.22% 0.79% 1.26% 0.75% 0.55% 0.50% 1.06% 0.86% 0.84% 0.55%
Earnings Yield		 6.88% 3.50% 6.96% 11.76% 2.42% 4.33% 5.83% 6.02% 0.00% 2.71% 2.75%
Enterprise Value to Invested Capital (EV/IC)		 2.23 2.24 3.30 1.98 2.59 3.43 3.47 1.12 1.68 1.76 2.28
Enterprise Value to Revenue (EV/Rev)		 1.38 2.45 2.46 1.43 3.24 3.46 3.13 2.69 2.96 3.02 3.62
Enterprise Value to EBITDA (EV/EBITDA)		 6.26 12.90 8.29 5.14 18.04 14.58 11.60 10.26 0.00 12.34 16.16
Enterprise Value to EBIT (EV/EBIT)		 7.14 20.36 9.91 6.02 28.42 17.88 13.38 15.75 0.00 21.67 27.83
Enterprise Value to NOPAT (EV/NOPAT)		 9.31 24.67 15.30 7.34 35.45 21.47 15.94 20.11 0.00 20.61 27.81
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.09 17.64 13.27 7.16 25.17 15.72 14.42 18.04 33.64 20.52 22.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.45 0.00 15.66 8.74 0.00 19.91 34.82 0.00 10.46 14.15 34.47
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.49 0.25 0.19 0.44 0.35 0.28 1.10 1.94 1.95 1.55
Long-Term Debt to Equity		 0.00 0.48 0.25 0.18 0.43 0.35 0.28 1.08 1.90 1.93 1.53
Financial Leverage		 -0.56 -0.20 0.01 -0.16 -0.01 0.08 -0.05 0.51 1.14 1.61 1.46
Leverage Ratio		 1.11 1.45 1.63 1.45 1.55 1.67 1.61 2.18 2.96 3.69 3.45
Compound Leverage Factor		 1.13 1.19 1.54 1.42 1.27 1.57 1.55 1.55 3.61 1.33 2.05
Debt to Total Capital		 0.00% 33.02% 19.83% 15.66% 30.40% 26.00% 22.06% 52.36% 65.96% 66.15% 60.71%
Short-Term Debt to Total Capital		 0.00% 0.59% 0.15% 0.18% 0.42% 0.45% 0.24% 0.99% 1.28% 0.73% 0.74%
Long-Term Debt to Total Capital		 0.00% 32.43% 19.68% 15.48% 29.99% 25.55% 21.81% 51.37% 64.67% 65.42% 59.97%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 66.98% 80.17% 84.34% 69.60% 74.00% 77.94% 47.64% 34.04% 33.85% 39.29%
Debt to EBITDA		 0.00 2.49 0.69 0.60 2.59 1.50 1.03 5.30 -4.16 5.17 4.76
Net Debt to EBITDA		 0.00 0.73 -0.28 -0.66 1.04 -0.02 -0.28 4.32 -3.40 4.36 4.00
Long-Term Debt to EBITDA		 0.00 2.44 0.69 0.60 2.55 1.47 1.02 5.20 -4.08 5.11 4.71
Debt to NOPAT		 0.00 4.75 1.28 0.86 5.09 2.21 1.41 10.38 -4.40 8.63 8.20
Net Debt to NOPAT		 0.00 1.39 -0.52 -0.94 2.04 -0.03 -0.39 8.47 -3.60 7.27 6.88
Long-Term Debt to NOPAT		 0.00 4.67 1.27 0.85 5.02 2.17 1.40 10.19 -4.32 8.54 8.10
Altman Z-Score		 11.79 3.40 5.92 5.25 4.14 5.09 5.64 1.42 0.74 1.60 2.03
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 10.33 4.21 4.27 5.56 4.51 4.83 4.67 2.93 3.18 3.19 2.71
Quick Ratio		 8.35 2.81 2.91 3.85 2.72 3.29 3.23 1.71 1.74 1.71 1.43
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 107 -789 301 339 -711 405 265 -5,363 1,026 766 413
Operating Cash Flow to CapEx		 1,114.02% 941.79% 1,135.37% 657.87% 1,121.56% 603.53% 735.63% 341.29% 379.76% 451.28% 444.83%
Free Cash Flow to Firm to Interest Expense		 748.62 -25.79 9.71 20.06 -16.13 13.97 10.60 -30.30 2.82 2.25 1.86
Operating Cash Flow to Interest Expense		 967.10 5.88 11.46 24.49 5.54 17.69 25.60 2.99 0.88 1.55 2.91
Operating Cash Flow Less CapEx to Interest Expense		 880.29 5.26 10.45 20.76 5.05 14.76 22.12 2.11 0.65 1.21 2.25
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.65 0.74 0.83 0.83 0.63 0.64 0.70 0.44 0.35 0.41 0.45
Accounts Receivable Turnover		 7.81 7.39 6.98 6.97 5.97 6.35 7.06 6.10 5.48 5.89 6.21
Inventory Turnover		 2.93 0.00 3.33 3.03 2.53 2.66 2.91 2.57 2.01 1.99 2.31
Fixed Asset Turnover		 11.49 10.64 11.06 11.33 8.71 8.86 9.67 6.30 4.57 4.61 4.97
Accounts Payable Turnover		 15.72 0.00 13.49 13.17 12.42 12.87 11.27 6.73 5.26 5.62 5.60
Days Sales Outstanding (DSO)		 46.72 49.40 52.30 52.40 61.15 57.48 51.70 59.84 66.66 61.99 58.78
Days Inventory Outstanding (DIO)		 124.65 0.00 109.54 120.56 144.51 137.27 125.36 141.80 181.39 183.08 158.10
Days Payable Outstanding (DPO)		 23.22 0.00 27.05 27.71 29.39 28.35 32.39 54.20 69.41 64.91 65.19
Cash Conversion Cycle (CCC)		 148.14 49.40 134.79 145.25 176.27 166.39 144.67 147.44 178.65 180.16 151.68
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 503 1,421 1,428 1,493 2,377 2,348 2,662 8,500 6,386 6,146 6,245
Invested Capital Turnover		 1.64 1.35 1.35 1.42 0.98 0.99 1.18 0.64 0.49 0.57 0.63
Increase / (Decrease) in Invested Capital		 13 918 7.11 65 885 -29 314 5,838 -2,114 -240 99
Enterprise Value (EV)		 1,119 3,177 4,713 2,961 6,154 8,065 9,231 9,545 10,730 10,834 14,249
Market Capitalization		 1,777 2,998 4,874 3,342 5,800 8,078 9,456 5,528 6,816 7,010 10,723
Book Value per Share		 $21.80 $23.17 $29.26 $34.70 $37.12 $42.82 $52.06 $67.41 $36.96 $34.50 $40.48
Tangible Book Value per Share		 $17.22 $4.58 $11.63 $17.90 $7.34 $14.19 $19.53 ($45.08) ($40.39) ($36.09) ($29.70)
Total Capital		 1,161 1,854 1,982 2,221 2,907 3,190 3,704 9,410 7,261 6,860 6,920
Total Debt		 0.00 612 393 348 884 830 817 4,927 4,789 4,538 4,201
Total Long-Term Debt		 0.00 601 390 344 872 815 808 4,834 4,696 4,488 4,150
Net Debt		 -658 179 -161 -381 354 -13 -225 4,017 3,914 3,824 3,526
Capital Expenditures (CapEx)		 12 19 31 63 22 85 87 155 84 117 145
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 190 349 406 487 604 609 654 1,025 1,066 1,035 959
Debt-free Net Working Capital (DFNWC)		 849 772 949 1,205 1,128 1,445 1,696 1,935 1,941 1,749 1,634
Net Working Capital (NWC)		 849 761 946 1,201 1,116 1,431 1,687 1,842 1,848 1,699 1,583
Net Nonoperating Expense (NNE)		 -2.19 24 -31 11 33 26 28 142 753 336 217
Net Nonoperating Obligations (NNO)		 -658 179 -161 -381 354 -13 -225 4,017 3,914 3,824 3,526
Total Depreciation and Amortization (D&A)		 22 90 93 85 125 102 106 324 430 378 370
Debt-free, Cash-free Net Working Capital to Revenue		 23.39% 26.95% 21.19% 23.45% 31.79% 26.14% 22.17% 28.90% 29.43% 28.86% 24.40%
Debt-free Net Working Capital to Revenue		 104.30% 59.63% 49.55% 58.06% 59.37% 62.02% 57.49% 54.55% 53.59% 48.77% 41.57%
Net Working Capital to Revenue		 104.30% 58.79% 49.40% 57.87% 58.73% 61.39% 57.19% 51.93% 51.02% 47.38% 40.27%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.30 $1.96 $6.26 $7.22 $2.57 $6.36 $9.95 $5.57 ($27.54) $2.82 $4.39
Adjusted Weighted Average Basic Shares Outstanding		 53.28M 53.47M 54.14M 54.41M 54.71M 55.10M 55.40M 59.70M 66.80M 67.30M 67.30M
Adjusted Diluted Earnings per Share		 $2.28 $1.94 $6.16 $7.14 $2.55 $6.33 $9.90 $5.56 ($27.54) $2.81 $4.37
Adjusted Weighted Average Diluted Shares Outstanding		 53.56M 54.05M 55.07M 54.99M 55.11M 55.30M 55.70M 59.90M 66.80M 67.60M 67.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 53.24M 53.82M 54.49M 54.20M 54.87M 55.22M 55.52M 66.67M 67.06M 67.38M 67.25M
Normalized Net Operating Profit after Tax (NOPAT)		 122 156 320 410 207 387 613 517 267 359 548
Normalized NOPAT Margin		 14.96% 12.02% 16.71% 19.75% 10.89% 16.62% 20.78% 14.57% 7.38% 10.01% 13.95%
Pre Tax Income Margin		 19.60% 9.88% 23.36% 23.18% 9.36% 18.15% 22.54% 12.21% -53.23% 5.02% 7.73%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1,095.19 5.10 15.35 29.12 4.91 15.55 27.60 3.42 -4.34 1.47 2.31
NOPAT to Interest Expense		 839.91 4.21 9.94 23.88 3.94 12.95 23.17 2.68 -2.99 1.54 2.31
EBIT Less CapEx to Interest Expense		 1,008.38 4.47 14.34 25.40 4.42 12.62 24.12 2.55 -4.57 1.12 1.65
NOPAT Less CapEx to Interest Expense		 753.10 3.58 8.93 20.16 3.44 10.02 19.69 1.81 -3.22 1.20 1.65
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 29.41% 34.69% 11.26% 10.79% 30.98% 12.57% 8.53% 15.62% -3.20% 31.05% 20.00%
Augmented Payout Ratio		 40.28% 36.17% 11.26% 29.88% 30.98% 12.57% 8.53% 15.62% -3.20% 31.05% 35.25%

Quarterly Metrics And Ratios for MKS

This table displays calculated financial ratios and metrics derived from MKS's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 67,248,357.00 67,544,129.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 67,248,357.00 67,544,129.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 1.25 2.59
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -17.77% 9.32% -11.57% -3.86% 4.70% 7.83% 9.70% 10.27% 10.59% 15.17% 28.26%
EBITDA Growth		 -55.81% 73.73% 114.32% 2.36% 92.37% -0.98% -4.37% 5.53% 1.76% 17.73% 56.62%
EBIT Growth		 -91.89% 3,533.33% 107.85% 10.81% 1,016.67% 2.75% -6.72% 10.57% 3.73% 33.93% 102.40%
NOPAT Growth		 -87.93% 11,854.89% 111.18% -36.77% 869.42% 16.90% -12.44% -8.09% 10.92% 25.43% 77.39%
Net Income Growth		 -227.78% 135.71% 101.30% 58.97% 230.43% 246.67% 169.57% 19.35% 18.89% 61.54% 182.26%
EPS Growth		 -274.14% 134.38% 101.25% 58.62% 232.67% 250.00% 178.79% 19.57% 17.91% 53.25% 161.96%
Operating Cash Flow Growth		 -1.63% 81.08% 306.78% 1.88% -2.76% 110.45% 35.25% 20.86% -19.32% -62.41% 47.27%
Free Cash Flow Firm Growth		 137.34% 139.61% 110.35% -85.93% -81.41% -88.50% -81.81% -6.38% -81.29% -103.58% 85.76%
Invested Capital Growth		 -24.87% -25.60% -5.72% -2.23% -3.76% -2.56% 0.37% -2.17% 1.61% 2.14% 0.52%
Revenue Q/Q Growth		 -4.18% -2.80% 2.19% 1.01% 4.35% 0.11% 3.95% 1.54% 4.66% 4.26% 15.77%
EBITDA Q/Q Growth		 -44.34% 73.73% 11.71% -5.24% 4.61% -10.57% 7.88% 4.57% 0.87% 3.46% 43.51%
EBIT Q/Q Growth		 -89.19% 808.33% 22.94% -8.21% 8.94% -16.42% 11.61% 8.80% 2.21% 7.91% 68.67%
NOPAT Q/Q Growth		 -92.30% 419.78% 58.66% -0.38% 18.00% -37.32% 18.83% 4.58% 42.40% -29.12% 68.06%
Net Income Q/Q Growth		 -276.92% 121.74% 53.33% 169.57% 45.16% -42.22% 19.23% 19.35% 44.59% -21.50% 108.33%
EPS Q/Q Growth		 -274.14% 121.78% 50.00% 178.79% 45.65% -42.54% 19.48% 19.57% 43.64% -25.32% 104.24%
Operating Cash Flow Q/Q Growth		 13.13% -62.98% 82.09% 33.61% 7.98% -19.89% 17.02% 19.39% -27.92% -62.68% 358.49%
Free Cash Flow Firm Q/Q Growth		 8.06% 6.04% -77.30% -45.93% 42.85% -34.40% -64.11% 178.36% -71.44% -112.54% 1,963.77%
Invested Capital Q/Q Growth		 -1.60% -1.03% -0.89% 1.29% -3.14% 0.20% 2.09% -1.27% 0.61% 0.72% 0.48%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 46.02% 47.81% 47.24% 48.21% 47.27% 47.44% 46.56% 46.66% 46.33% 47.03% 47.68%
EBITDA Margin		 13.21% 23.62% 25.82% 24.22% 24.28% 21.69% 22.51% 23.18% 22.34% 22.17% 27.48%
Operating Margin		 2.58% 12.21% 14.32% 14.29% 14.65% 11.86% 13.87% 13.97% 13.93% 13.82% 20.11%
EBIT Margin		 1.34% 12.56% 15.11% 13.73% 14.33% 11.97% 12.85% 13.77% 13.44% 13.91% 20.27%
Profit (Net Income) Margin		 -7.73% 1.73% 2.59% 6.92% 9.63% 5.56% 6.37% 7.49% 10.35% 7.79% 14.02%
Tax Burden Percent		 86.25% 78.95% 104.55% 103.33% 113.92% 88.14% 86.11% 88.10% 120.22% 82.35% 82.16%
Interest Burden Percent		 -666.67% 17.43% 16.42% 48.78% 58.96% 52.68% 57.60% 61.76% 64.03% 68.00% 84.19%
Effective Tax Rate		 0.00% 21.05% -4.55% -3.33% -13.92% 11.86% 13.89% 11.90% -20.22% 17.65% 17.84%
Return on Invested Capital (ROIC)		 0.88% 4.81% 8.30% 8.15% 9.55% 6.12% 7.12% 7.51% 10.62% 7.45% 11.40%
ROIC Less NNEP Spread (ROIC-NNEP)		 -1.27% 3.08% 5.62% 6.39% 7.85% 4.93% 5.72% 6.25% 8.82% 6.39% 10.51%
Return on Net Nonoperating Assets (RNNOA)		 -1.45% 3.56% 9.72% 10.43% 12.66% 7.95% 9.29% 9.45% 12.87% 9.00% 13.41%
Return on Equity (ROE)		 -0.57% 8.37% 18.02% 18.58% 22.22% 14.07% 16.41% 16.96% 23.49% 16.45% 24.81%
Cash Return on Invested Capital (CROIC)		 13.79% 15.67% 9.94% 11.09% 12.22% 10.92% 7.66% 10.05% 6.67% 6.45% 9.23%
Operating Return on Assets (OROA)		 0.47% 4.57% 5.98% 5.36% 5.80% 5.00% 5.43% 5.93% 6.08% 6.56% 9.92%
Return on Assets (ROA)		 -2.72% 0.63% 1.03% 2.70% 3.90% 2.32% 2.69% 3.22% 4.68% 3.67% 6.86%
Return on Common Equity (ROCE)		 -0.57% 8.37% 18.02% 18.58% 22.22% 14.07% 16.41% 16.96% 23.49% 16.45% 24.81%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -73.60% 0.36% 1.29% 0.00% 9.64% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 16 84 133 132 156 98 116 122 173 123 206
NOPAT Margin		 1.80% 9.64% 14.97% 14.76% 16.69% 10.45% 11.95% 12.30% 16.74% 11.38% 16.52%
Net Nonoperating Expense Percent (NNEP)		 2.15% 1.73% 2.68% 1.77% 1.71% 1.19% 1.40% 1.26% 1.80% 1.06% 0.88%
Return On Investment Capital (ROIC_SIMPLE)		 0.22% - - - 2.28% 1.44% 1.67% 1.76% 2.50% 1.79% 2.98%
Cost of Revenue to Revenue		 53.98% 52.19% 52.76% 51.79% 52.73% 52.56% 53.44% 53.34% 53.68% 52.97% 52.32%
SG&A Expenses to Revenue		 18.14% 19.59% 18.15% 18.64% 18.82% 19.77% 17.99% 18.22% 17.80% 17.63% 16.03%
R&D to Revenue		 7.84% 8.06% 7.44% 7.81% 6.95% 7.48% 7.81% 7.69% 7.45% 7.51% 6.09%
Operating Expenses to Revenue		 43.45% 35.60% 32.92% 33.93% 32.62% 35.58% 32.68% 32.69% 32.40% 33.21% 27.56%
Earnings before Interest and Taxes (EBIT)		 12 109 134 123 134 112 125 136 139 150 253
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 118 205 229 217 227 203 219 229 231 239 343
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.76 3.66 3.93 3.05 3.02 2.29 2.61 3.20 3.94 5.50 10.05
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.88 2.40 2.45 2.06 1.95 1.48 1.78 2.17 2.73 3.79 6.91
Price to Earnings (P/E)		 0.00 0.00 1,096.82 235.96 36.90 23.79 25.05 29.90 36.35 47.26 68.28
Dividend Yield		 0.86% 0.66% 0.67% 0.81% 0.84% 1.10% 0.89% 0.71% 0.55% 0.40% 0.21%
Earnings Yield		 0.00% 0.00% 0.09% 0.42% 2.71% 4.20% 3.99% 3.34% 2.75% 2.12% 1.46%
Enterprise Value to Invested Capital (EV/IC)		 1.68 2.02 2.04 1.77 1.76 1.49 1.65 1.92 2.28 3.01 5.28
Enterprise Value to Revenue (EV/Rev)		 2.96 3.46 3.58 3.18 3.02 2.52 2.78 3.11 3.62 4.65 7.68
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 16.76 14.64 12.34 10.51 12.01 13.58 16.16 20.62 32.03
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 34.99 29.79 21.67 18.30 21.05 23.51 27.83 34.42 49.23
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 48.91 19.87 20.61 17.73 20.65 24.19 27.81 35.50 54.28
Enterprise Value to Operating Cash Flow (EV/OCF)		 33.64 36.61 24.16 21.13 20.52 15.29 16.12 17.55 22.09 33.99 52.56
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.46 11.01 19.95 15.82 14.15 13.52 21.64 18.90 34.47 47.17 57.35
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.94 1.96 2.19 2.01 1.95 1.89 1.73 1.66 1.55 1.44 1.32
Long-Term Debt to Equity		 1.90 1.94 2.16 1.98 1.93 1.87 1.71 1.64 1.53 0.94 0.85
Financial Leverage		 1.14 1.15 1.73 1.63 1.61 1.61 1.62 1.51 1.46 1.41 1.28
Leverage Ratio		 2.96 2.95 3.83 3.73 3.69 3.66 3.70 3.56 3.45 3.35 3.21
Compound Leverage Factor		 -19.76 0.51 0.63 1.82 2.18 1.93 2.13 2.20 2.21 2.28 2.70
Debt to Total Capital		 65.96% 66.17% 68.62% 66.72% 66.15% 65.45% 63.32% 62.34% 60.71% 59.02% 56.89%
Short-Term Debt to Total Capital		 1.28% 0.70% 0.70% 0.69% 0.73% 0.73% 0.73% 0.74% 0.74% 20.38% 20.18%
Long-Term Debt to Total Capital		 64.67% 65.48% 67.91% 66.03% 65.42% 64.71% 62.59% 61.60% 59.97% 38.64% 36.70%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 34.04% 33.83% 31.38% 33.28% 33.85% 34.55% 36.68% 37.66% 39.29% 40.98% 43.11%
Debt to EBITDA		 -4.16 -4.46 6.39 6.25 5.17 5.09 5.09 4.90 4.76 4.41 3.78
Net Debt to EBITDA		 -3.40 -3.66 5.28 5.13 4.36 4.34 4.31 4.11 4.00 3.79 3.20
Long-Term Debt to EBITDA		 -4.08 -4.41 6.32 6.19 5.11 5.03 5.03 4.84 4.71 2.89 2.44
Debt to NOPAT		 -4.40 -4.68 18.65 8.48 8.63 8.59 8.76 8.74 8.20 7.59 6.41
Net Debt to NOPAT		 -3.60 -3.84 15.40 6.96 7.27 7.33 7.42 7.32 6.88 6.52 5.42
Long-Term Debt to NOPAT		 -4.32 -4.63 18.46 8.39 8.54 8.50 8.65 8.63 8.10 4.97 4.14
Altman Z-Score		 1.32 1.59 1.57 1.42 1.46 1.31 1.42 1.62 1.89 2.25 3.80
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.18 3.69 3.58 3.42 3.19 3.11 2.99 2.86 2.71 1.11 1.14
Quick Ratio		 1.74 1.97 1.96 1.88 1.71 1.66 1.59 1.48 1.43 0.59 0.59
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2,130 2,259 513 277 396 260 93 260 74 -9.29 173
Operating Cash Flow to CapEx		 532.35% 372.22% 469.23% 740.91% 345.10% 783.33% 568.97% 394.00% 284.00% 212.00% 450.00%
Free Cash Flow to Firm to Interest Expense		 21.74 23.53 4.38 4.02 6.71 4.64 1.64 4.72 1.37 -0.19 4.12
Operating Cash Flow to Interest Expense		 1.85 0.70 1.04 2.36 2.98 2.52 2.89 3.58 2.63 1.06 5.79
Operating Cash Flow Less CapEx to Interest Expense		 1.50 0.51 0.82 2.04 2.12 2.20 2.39 2.67 1.70 0.56 4.50
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.35 0.36 0.40 0.39 0.41 0.42 0.42 0.43 0.45 0.47 0.49
Accounts Receivable Turnover		 5.48 6.44 5.83 5.78 5.89 6.01 6.00 6.28 6.21 5.76 5.88
Inventory Turnover		 2.01 1.95 1.93 1.92 1.99 2.06 2.12 2.17 2.31 2.36 2.36
Fixed Asset Turnover		 4.57 4.74 4.66 4.63 4.61 4.75 4.79 4.98 4.97 5.19 5.44
Accounts Payable Turnover		 5.26 5.96 6.31 6.07 5.62 6.25 6.10 5.91 5.60 5.64 5.19
Days Sales Outstanding (DSO)		 66.66 56.69 62.60 63.19 61.99 60.68 60.80 58.10 58.78 63.36 62.08
Days Inventory Outstanding (DIO)		 181.39 187.58 188.71 190.52 183.08 177.55 172.03 168.31 158.10 154.78 154.40
Days Payable Outstanding (DPO)		 69.41 61.20 57.84 60.12 64.91 58.36 59.88 61.79 65.19 64.75 70.36
Cash Conversion Cycle (CCC)		 178.65 183.07 193.48 193.58 180.16 179.87 172.95 164.62 151.68 153.39 146.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 6,386 6,320 6,264 6,345 6,146 6,158 6,287 6,207 6,245 6,290 6,320
Invested Capital Turnover		 0.49 0.50 0.55 0.55 0.57 0.59 0.60 0.61 0.63 0.65 0.69
Increase / (Decrease) in Invested Capital		 -2,114 -2,175 -380 -145 -240 -162 23 -138 99 132 33
Enterprise Value (EV)		 10,730 12,776 12,806 11,262 10,834 9,204 10,398 11,919 14,249 18,933 33,376
Market Capitalization		 6,816 8,880 8,775 7,315 7,010 5,400 6,664 8,312 10,723 15,454 30,044
Book Value per Share		 $36.96 $36.18 $33.23 $35.64 $34.50 $34.94 $38.06 $38.71 $40.48 $41.80 $44.24
Tangible Book Value per Share		 ($40.39) ($38.63) ($39.88) ($38.82) ($36.09) ($35.32) ($34.05) ($32.15) ($29.70) ($27.05) ($23.79)
Total Capital		 7,261 7,166 7,115 7,206 6,860 6,813 6,961 6,904 6,920 6,859 6,931
Total Debt		 4,789 4,742 4,882 4,808 4,538 4,459 4,408 4,304 4,201 4,048 3,943
Total Long-Term Debt		 4,696 4,692 4,832 4,758 4,488 4,409 4,357 4,253 4,150 2,650 2,544
Net Debt		 3,914 3,896 4,031 3,947 3,824 3,804 3,734 3,607 3,526 3,479 3,332
Capital Expenditures (CapEx)		 34 18 26 22 51 18 29 50 50 25 54
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1,066 1,144 1,107 1,076 1,035 1,040 1,029 1,004 959 1,083 1,138
Debt-free Net Working Capital (DFNWC)		 1,941 1,990 1,958 1,937 1,749 1,695 1,703 1,701 1,634 1,652 1,749
Net Working Capital (NWC)		 1,848 1,940 1,908 1,887 1,699 1,645 1,652 1,650 1,583 254 350
Net Nonoperating Expense (NNE)		 85 69 110 70 66 46 54 48 66 39 31
Net Nonoperating Obligations (NNO)		 3,914 3,896 4,031 3,947 3,824 3,804 3,734 3,607 3,526 3,479 3,332
Total Depreciation and Amortization (D&A)		 106 96 95 94 93 91 94 93 92 89 90
Debt-free, Cash-free Net Working Capital to Revenue		 29.43% 30.95% 30.92% 30.36% 28.86% 28.46% 27.51% 26.20% 24.40% 26.59% 26.17%
Debt-free Net Working Capital to Revenue		 53.59% 53.84% 54.69% 54.66% 48.77% 46.39% 45.53% 44.39% 41.57% 40.56% 40.23%
Net Working Capital to Revenue		 51.02% 52.49% 53.30% 53.24% 47.38% 45.02% 44.17% 43.06% 40.27% 6.24% 8.05%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.02) $0.22 $0.34 $0.92 $1.34 $0.77 $0.92 $1.10 $1.60 $1.24 $2.59
Adjusted Weighted Average Basic Shares Outstanding		 66.80M 67M 67.30M 67.40M 67.30M 67.40M 67.20M 67.30M 67.30M 67.40M 67.60M
Adjusted Diluted Earnings per Share		 ($1.01) $0.22 $0.33 $0.92 $1.34 $0.77 $0.92 $1.10 $1.58 $1.18 $2.41
Adjusted Weighted Average Diluted Shares Outstanding		 66.80M 67.40M 67.50M 67.60M 67.60M 67.70M 67.40M 67.60M 67.70M 71.10M 72.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 67.06M 67.20M 67.29M 67.30M 67.38M 67.07M 67.16M 67.17M 67.25M 67.54M 67.62M
Normalized Net Operating Profit after Tax (NOPAT)		 75 87 92 92 98 112 121 125 109 128 211
Normalized NOPAT Margin		 8.39% 10.00% 10.34% 10.31% 10.48% 11.96% 12.39% 12.66% 10.56% 11.84% 16.92%
Pre Tax Income Margin		 -8.96% 2.19% 2.48% 6.70% 8.45% 6.30% 7.40% 8.50% 8.61% 9.46% 17.07%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.12 1.14 1.15 1.78 2.27 2.00 2.19 2.47 2.57 3.00 6.02
NOPAT to Interest Expense		 0.16 0.87 1.13 1.92 2.65 1.75 2.04 2.21 3.21 2.45 4.91
EBIT Less CapEx to Interest Expense		 -0.22 0.95 0.92 1.46 1.41 1.68 1.68 1.56 1.65 2.50 4.74
NOPAT Less CapEx to Interest Expense		 -0.18 0.68 0.91 1.60 1.78 1.43 1.53 1.30 2.28 1.95 3.62
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -3.20% -3.31% 750.00% 190.32% 31.05% 25.99% 22.18% 21.22% 20.00% 18.65% 14.32%
Augmented Payout Ratio		 -3.20% -3.31% 750.00% 190.32% 31.05% 25.99% 22.18% 21.22% 35.25% 18.65% 14.32%

Financials Breakdown Chart

Key Financial Trends

MKS Instruments (NASDAQ: MKSI) showed improving quarterly profitability and cash generation in Q1 2026, but the balance sheet still carries a heavy debt load and a large amount of acquired intangibles/goodwill. Over the last several years, the company has moved from a difficult 2022–2023 period into a more stable 2024–2026 run, with revenue recovering, margins improving, and operating cash flow staying positive. That said, leverage remains the main risk for investors.

  • Revenue continued to grow. Q1 2026 revenue rose to $1.078 billion from $1.034 billion in Q4 2025 and $988 million in Q3 2025, showing a steady top-line recovery.
  • Gross profit improved alongside sales. Q1 2026 gross profit was $507 million, up from $479 million in Q4 2025 and $461 million in Q3 2025.
  • Operating income remained solid. Q1 2026 operating income was $149 million, slightly ahead of recent quarters, indicating the business is holding operating discipline.
  • Operating cash flow was positive. The company generated $53 million of operating cash flow in Q1 2026, following $142 million in Q4 2025 and $197 million in Q3 2025.
  • Net income stayed positive. Q1 2026 net income was $84 million, down from Q4 2025’s $107 million but still comfortably profitable.
  • Share count has been fairly stable. Diluted shares were 71.1 million in Q1 2026 versus 67.7 million in Q4 2025, so dilution has not become a major growth drag recently.
  • Capital spending appears moderate. Q1 2026 capex was $25 million, which is manageable relative to operating cash flow and revenue size.
  • Quarterly dividends continue. The company paid $0.25 per share in Q1 2026, suggesting ongoing capital returns, though not a large yield signal from this data alone.
  • Debt remains elevated. At Q1 2026, short-term debt was $1.398 billion and long-term debt was $2.650 billion, for roughly $4.05 billion of total debt.
  • Balance sheet leverage is still significant. Total liabilities were $5.917 billion against $2.811 billion of equity, leaving MKSI with a levered capital structure.

Longer-term trend: MKSI’s results look much healthier than the weaker 2022–2023 period, when profits were pressured and some quarters included large impairment charges. Since 2024, revenue has generally trended upward, operating income has stabilized, and cash generation has improved. The company also appears to have worked down some near-term debt versus the more volatile debt moves seen in 2023–2024.

What investors should watch next: whether revenue growth continues, whether operating cash flow can stay consistently above capital spending and dividend needs, and whether management keeps reducing debt. If MKSI can maintain current earnings momentum while lowering leverage, the stock’s financial profile would look meaningfully stronger.

08/09/26 03:07 PM ETAI Generated. May Contain Errors.

MKS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, MKS's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

MKS's net income appears to be on a downward trend, with a most recent value of $295 million in 2025, rising from $122.30 million in 2015. The previous period was $190 million in 2024. View MKS's forecast to see where analysts expect MKS to go next.

MKS's total operating income in 2025 was $528 million, based on the following breakdown:
  • Total Gross Profit: $1.84 billion
  • Total Operating Expenses: $1.31 billion

Over the last 10 years, MKS's total revenue changed from $813.52 million in 2015 to $3.93 billion in 2025, a change of 383.2%.

MKS's total liabilities were at $6.08 billion at the end of 2025, a 3.0% decrease from 2024, and a 5,303.4% increase since 2015.

In the past 10 years, MKS's cash and equivalents has ranged from $227.57 million in 2015 to $966 million in 2021, and is currently $675 million as of their latest financial filing in 2025.

Over the last 10 years, MKS's book value per share changed from 21.80 in 2015 to 40.48 in 2025, a change of 85.7%.


Related Companies

Financial statements for NASDAQ:MKSI last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel